Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico.Long-term effect of intravenous thrombolysis in acute myocardial infarction. Final Report of the GISSI Study . Lancet1987;2:871-874
2.
Wilcox RG, Olsson CB, Skene AM, et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet1988;2:525-530
3.
ISIS 2 Collaborative Group.Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS 2. Lancet1988;2:349-360
4.
TheAIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet1988; 1:545-549
5.
Van der Werf F., for the Investigators of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator.Lessons from the European Cooperative Recombinant Tissue-Type Plasminogen Activator (rt-PA) versus Placebo Trial. J Am Coll Cardiol1988;12(suppl A):14A-19A
6.
Van de Werf F.Discrepancies between the effects of coronary reperfusion on survival and left ventricular function. Lancet1989;1:1367-1369
7.
Kennedy JW, Ritchie JL, Davis KB, et al. TheWestern Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction: A 12-month follow-up report. N Engl J Med1985;312:1073-1078
8.
Dalen JE, Gore JM, Braunwald E., et al. Six- and twelve-month follow-up of the Phase I Thrombolysis in Myocardial Infarction (TIMI) Trial. Am J Cardiol1988;62:179-185
9.
Hochman JS, Choo H.Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation1987;75:299-306
10.
Sager PT, Perlmutter RA, Rosenfeld LE, et al. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol1988 ; 12:19-24
11.
Gang ES, Lew AS, Hong M., et al. Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med1989; 321:712-716
12.
ISAM Study Group.A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity and infarct size at 21 days. N Engl J Med1986; 314:1456-1471
13.
Miller DDDetection of viable myocardium after myocardial infarction. J Intensive Care Med1990;5:7-22
14.
Gibbons RJ, Verani MS, Pellika PA, et al. Feasibility of Tc-99m methoxy isobutyl nitrile (MIBI) for the tomographic evaluation of myocardium at risk in acute myocardial infarction . Circulation1988;78(suppl II):II-387
15.
Faraggi M., Assayag P., Brochet E., et al. Assessment of myocardial perfusion in acute myocardial infarction (AMI) and thrombolysis with methoxy-isobutyl isonitrile (MIBI) tomography . Circulation1988;78(suppl II):II-387
16.
Johnston DC , Liv P., Ross BRIn vivo detection of reperfused myocardium by nuclear magnetic resonance imaging. J Am Coll Cardiol1987;9:127-135
